This was further confirmed by immunohistostaining, which identified JAK2 phosphorylation with two distinct forms of activation: a cytoplasmic form of JAK2 activation in most IPF cases and a nuclear form of p-JAK2 in RA-UIP and a minority of IPF cases. The gene discussed is JAK2; the disease is idiopathic pulmonary fibrosis.